Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid Metformin vs Tablets in Healthy Adults
NCT07300059Phase 1Not yet recruiting
- Sponsor
- Aspargo Laboratories
- Start
- Jul 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Aspargo Laboratories. Primary endpoint: Area Under the Blood Glucose-Time Curve from 0 to 4 Hours Postdose. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07300059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07300059.